Joy Liu advises drug, biotech, and device companies on a broad range of FDA regulatory matters. Joy has significant experience working on advertising and promotion compliance matters, Hatch-Waxman patent and exclusivity issues, and regulatory risk management. She has also worked on a number of government investigations, helping to defend companies during civil and criminal investigations concerning off-label promotion, recalls, safety reporting, and GMPs. In addition, Joy’s perspective is bolstered by her in-house counsel experience gained during an eight-month secondment to a multinational pharmaceutical company, where she worked as the sole product attorney for a $3 billion drug, sat on the copy review committee, and advised on fraud and abuse issues. Joy serves on the Board of Directors of the Food and Drug Law Institute and is a member of the Editorial Advisory Board for the Food and Drug Law Journal.